KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Return on Sales (2016 - 2025)

Precigen (PGEN) has disclosed Return on Sales for 14 consecutive years, with 28.91% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 5475.0% to 28.91% in Q3 2025 year-over-year; TTM through Sep 2025 was 48.43%, a 6984.0% decrease, with the full-year FY2022 number at 7.42%, up 603.0% from a year prior.
  • Return on Sales was 28.91% for Q3 2025 at Precigen, up from 783.59% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 896.68% in Q4 2024 to a low of 2354.48% in Q1 2025.
  • A 5-year average of 244.11% and a median of 0.01% in 2021 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was 111293bps in 2025; the steepest drop was -232865bps in 2025.
  • Precigen's Return on Sales stood at 0.35% in 2021, then surged by 2219bps to 7.42% in 2022, then soared by 31bps to 9.74% in 2023, then skyrocketed by 9105bps to 896.68% in 2024, then plummeted by -103bps to 28.91% in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Return on Sales are 28.91% (Q3 2025), 783.59% (Q2 2025), and 2354.48% (Q1 2025).